John B. Sanfilippo & Son, Inc.
JBSSConsumer DefensiveNASDAQPackaged Foods · Last scanned Sep 8, 2026
Scan Results
Daily timeframeHeadquartered within the consumer defensive sector, John B. Sanfilippo & Son, Inc. focuses on Packaged Foods services and products. Sanfilippo & Son, Inc., through its subsidiary, JBSS Ventures, LLC, engages in the process and distribution of tree nuts and peanuts in the United States. At a $828.1M market cap, John B. Sanfilippo & Son, Inc. ranks as a small-cap company within consumer defensive. The company offers raw and processed nuts, including almonds, pecans, peanuts, walnuts, cashews, macadamia nuts, pistachios, pine nuts, and filberts in various styles and seasonings; and bar product line, including chewy granola, fruit and grain, sweet and salty, dipped chewy granola, crunchy, energy, fiber, nut, fig, and protein bars.
Market Cap
$828.1M
Beta
0.32
P/E (TTM)
13.47
P/E (Fwd)
14.88
EPS (TTM)
$5.26
EPS (Fwd)
$4.76
ROE
16.7%
ROA
8.5%
Cash
$1.1M
Total Debt
$109.3M
Free CF
$29.0M
52W Change
16.4%
Annual Financials
Cash vs Debt
Where JBSS stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, JBSS finished 4.82% below its 150-day moving average ($77.64) and 2.17% below its 200-day moving average ($75.54). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is JBSS overbought or oversold?
At the September 3, 2026 close, JBSS's RSI(14) was 20.1, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, JBSS has $1.1M in cash with $109.3M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $29.0M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 16.7% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 8.5% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $999.7M to $1.18B.
The relatively low beta of 0.32 suggests JBSS is a less volatile holding compared to the broader index. The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. No single metric tells the full story. Reviewing JBSS's risk profile alongside its fundamentals and technical indicators provides a more complete picture.